Skip to main content
Top
Published in: Journal of Gastroenterology 1/2024

16-10-2023 | Original Article―Liver, Pancreas, and Biliary Tract

A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease

Authors: Tatsunori Hanai, Kayoko Nishimura, Shinji Unome, Takao Miwa, Yuki Nakahata, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu

Published in: Journal of Gastroenterology | Issue 1/2024

Login to get access

Abstract

Background

Physical activity can reduce the risk of morbidity and mortality in patients with chronic liver disease (CLD), whereas physical inactivity adversely affects clinical outcomes. Since data on physical activity in CLD are scarce, we conducted a questionnaire survey to assess the physical activity patterns and determinants in patients with CLD.

Methods

We surveyed 437 patients from outpatient clinics at Gifu University Hospital about their physical activity patterns and determinants in 2022 using a validated questionnaire. The primary objective was to examine the proportion of patients who exercised and the clinical characteristics of patients who achieved high levels of physical activity. The secondary objectives were to explore the types, motivations, barriers, and preferences for physical activity.

Results

Among the 397 eligible patients (median age 68 years; 51% men; and median Model for End-Stage Liver Disease score 6), 55.4% reported performing physical activity less than once a week. Physical activity frequency was not associated with sex, body mass index, comorbidities, or hepatic reserve. Among the respondents, 60.4% expressed concern regarding physical strength, and 80.6% expressed concern regarding physical inactivity. The main barriers to physical activity were work, household chores, and health problems. However, many respondents expressed their willingness to increase their physical activity frequency with some promotional policies. Walking was the most common physical activity practiced in the past year and the activity most respondents wanted to try in the future.

Conclusions

Patients with CLD are insufficiently active and need physical activity interventions, especially regarding walking.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–62.CrossRefPubMed Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–62.CrossRefPubMed
3.
go back to reference Guthold R, Stevens GA, Riley LM, et al. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health. 2018;6:e1077–86.CrossRefPubMed Guthold R, Stevens GA, Riley LM, et al. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health. 2018;6:e1077–86.CrossRefPubMed
5.
go back to reference Ikeda N, Saito E, Kondo N, et al. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.CrossRefPubMed Ikeda N, Saito E, Kondo N, et al. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.CrossRefPubMed
7.
go back to reference Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: translating evidence and experience to practice. J Hepatol. 2018;69:1164–77.CrossRefPubMed Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: translating evidence and experience to practice. J Hepatol. 2018;69:1164–77.CrossRefPubMed
8.
go back to reference Carey EJ, Lai JC, Sonnenday C, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology. 2019;70:1816–29.CrossRefPubMed Carey EJ, Lai JC, Sonnenday C, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology. 2019;70:1816–29.CrossRefPubMed
9.
10.
go back to reference Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51:725–49.CrossRefPubMed Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51:725–49.CrossRefPubMed
11.
go back to reference Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951–63.CrossRefPubMedPubMedCentral Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951–63.CrossRefPubMedPubMedCentral
12.
go back to reference Hanai T, Nishimura K, Miwa T, et al. Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021;56:928–37.CrossRefPubMed Hanai T, Nishimura K, Miwa T, et al. Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021;56:928–37.CrossRefPubMed
13.
go back to reference Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, et al. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transplant. 2018;24:122–39.CrossRef Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, et al. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transplant. 2018;24:122–39.CrossRef
14.
go back to reference Baumeister SE, Leitzmann MF, Linseisen J, et al. Physical activity and the risk of liver cancer: a systematic review and meta-analysis of prospective studies and a bias analysis. J Natl Cancer Inst. 2019;111:1142–51.CrossRefPubMedPubMedCentral Baumeister SE, Leitzmann MF, Linseisen J, et al. Physical activity and the risk of liver cancer: a systematic review and meta-analysis of prospective studies and a bias analysis. J Natl Cancer Inst. 2019;111:1142–51.CrossRefPubMedPubMedCentral
15.
go back to reference EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.
16.
go back to reference Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325–36.CrossRefPubMedPubMedCentral Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325–36.CrossRefPubMedPubMedCentral
18.
go back to reference Simon TG, Kim MN, Luo X, et al. Physical activity compared to adiposity and risk of liver-related mortality: results from two prospective, nationwide cohorts. J Hepatol. 2020;72:1062–9.CrossRefPubMedPubMedCentral Simon TG, Kim MN, Luo X, et al. Physical activity compared to adiposity and risk of liver-related mortality: results from two prospective, nationwide cohorts. J Hepatol. 2020;72:1062–9.CrossRefPubMedPubMedCentral
19.
go back to reference Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2021;160:912–8.CrossRefPubMed Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2021;160:912–8.CrossRefPubMed
20.
go back to reference Lin FP, Bloomer PM, Grubbs RK, et al. Low daily step count is associated with a high risk of hospital admission and death in community-dwelling patients with cirrhosis. Clin Gastroenterol Hepatol. 2022;20:1813-1820.e2.CrossRefPubMedPubMedCentral Lin FP, Bloomer PM, Grubbs RK, et al. Low daily step count is associated with a high risk of hospital admission and death in community-dwelling patients with cirrhosis. Clin Gastroenterol Hepatol. 2022;20:1813-1820.e2.CrossRefPubMedPubMedCentral
21.
go back to reference Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. Lancet Public Health. 2022;7:e219–28.CrossRefPubMedPubMedCentral Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. Lancet Public Health. 2022;7:e219–28.CrossRefPubMedPubMedCentral
22.
go back to reference Chun HS, Lee M, Lee HA, et al. Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2023;21:358-369.e12.CrossRefPubMed Chun HS, Lee M, Lee HA, et al. Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2023;21:358-369.e12.CrossRefPubMed
23.
go back to reference Anstee QM, Hallsworth K, Lynch N, et al. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Rep. 2022;4: 100411.CrossRefPubMed Anstee QM, Hallsworth K, Lynch N, et al. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Rep. 2022;4: 100411.CrossRefPubMed
24.
go back to reference Jamali T, Raasikh T, Bustamante G, et al. Outcomes of exercise interventions in patients with advanced liver disease: a systematic review of randomized clinical trials. Am J Gastroenterol. 2022;117:1614–20.CrossRefPubMed Jamali T, Raasikh T, Bustamante G, et al. Outcomes of exercise interventions in patients with advanced liver disease: a systematic review of randomized clinical trials. Am J Gastroenterol. 2022;117:1614–20.CrossRefPubMed
25.
go back to reference Koya S, Kawaguchi T, Hashida R, et al. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2019;34:580–8.CrossRefPubMed Koya S, Kawaguchi T, Hashida R, et al. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2019;34:580–8.CrossRefPubMed
26.
go back to reference Liu XF, Zhu XD, Feng LH, et al. Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Exp Hematol Oncol. 2022;11:20.CrossRefPubMedPubMedCentral Liu XF, Zhu XD, Feng LH, et al. Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Exp Hematol Oncol. 2022;11:20.CrossRefPubMedPubMedCentral
27.
go back to reference Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–99.CrossRefPubMed Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;76:588–99.CrossRefPubMed
28.
go back to reference Hernández-Conde M, Llop E, Gómez-Pimpollo L, et al. Adding branched-chain amino acids to an enhanced standard-of-care treatment improves muscle mass of cirrhotic patients with sarcopenia: a placebo-controlled trial. Am J Gastroenterol. 2021;116:2241–9.CrossRefPubMed Hernández-Conde M, Llop E, Gómez-Pimpollo L, et al. Adding branched-chain amino acids to an enhanced standard-of-care treatment improves muscle mass of cirrhotic patients with sarcopenia: a placebo-controlled trial. Am J Gastroenterol. 2021;116:2241–9.CrossRefPubMed
29.
go back to reference Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–44.CrossRefPubMed Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–44.CrossRefPubMed
31.
go back to reference de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.CrossRefPubMed de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.CrossRefPubMed
32.
go back to reference Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305.CrossRefPubMed Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305.CrossRefPubMed
33.
go back to reference Kondo Y, Iwasa M, Kawaratani H, et al. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: a Japanese multicenter study. Hepatol Res. 2021;51:674–81.CrossRefPubMed Kondo Y, Iwasa M, Kawaratani H, et al. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: a Japanese multicenter study. Hepatol Res. 2021;51:674–81.CrossRefPubMed
Metadata
Title
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease
Authors
Tatsunori Hanai
Kayoko Nishimura
Shinji Unome
Takao Miwa
Yuki Nakahata
Kenji Imai
Atsushi Suetsugu
Koji Takai
Masahito Shimizu
Publication date
16-10-2023
Publisher
Springer Nature Singapore
Published in
Journal of Gastroenterology / Issue 1/2024
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-023-02047-x

Other articles of this Issue 1/2024

Journal of Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.